Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes

References

• Abu N, Akhtar MN, Yeap SK, Lim KL, Ho WY, Zulfadli AJ, Omar AR, Sulaiman MR, Abdullah MP, Alitheen NB. 2014. Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro. PLoS One. 9:e105244.
   PubMed Web of Science ®Google Scholar
• Abu N, Ho WY, Yeap SK, Akhtar MN, Abdullah MP, Omar AR, Alitheen NB. 2013. The flavokawains: uprising medicinal chalcones. Cancer Cell Int. 13:102.
   PubMed Web of Science ®Google Scholar
• Abu N, Mohamed NE, Yeap SK, Lim KL, Akhtar MN, Zulfadli AJ, Kee BB, Abdullah MP, Omar AR, Alitheen NB. 2015. In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice. Drug Des Dev Ther. 9:1401–1417.
   PubMed Web of Science ®Google Scholar
• An J, Gao Y, Wang J, Zhu Q, Ma Y, Wu J, Sun J, Tang Y. 2012. Flavokawain B induces apoptosis of non-small cell lung cancer H460 cells via Bax-initiated mitochondrial and JNK pathway. Biotechnol Lett. 34:1781–1788.
   PubMed Web of Science ®Google Scholar
• Anckar J, Sistonen L. 2011. Regulation of HSF1 function in the heat stress response: implications in aging and disease. Annu Rev Biochem. 80:1089–1115.
   PubMed Web of Science ®Google Scholar
• Baird L, Dinkova-Kostova AT. 2011. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol. 85:241–272.
   PubMed Web of Science ®Google Scholar
• Chen HC, Guh JY, Tsai JH, Lai YH. 1999. Induction of heat shock protein 70 protects mesangial cells against oxidative injury. Kidney Int. 56:1270–1273.
   PubMed Web of Science ®Google Scholar
• Chiu HY, Tsao LY, Yang RC. 2009. Heat-shock response protects peripheral blood mononuclear cells (PBMCs) from hydrogen peroxide-induced mitochondrial disturbance. Cell Stress Chaperones. 14:207–217.
   PubMed Web of Science ®Google Scholar
• Clarke JD, Dashwood RH, Ho E. 2008. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 269:291–304.
   PubMed Web of Science ®Google Scholar
• Connor RE, Marnett LJ, Liebler DC. 2011. Protein-selective capture to analyze electrophile adduction of hsp90 by 4-hydroxynonenal. Chem Res Toxicol. 24:1275–1282.
   PubMed Web of Science ®Google Scholar
• Currie BJ, Clough AR. 2003. Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use? Med J Aust. 178:421–422.
   PubMed Web of Science ®Google Scholar
• Dharmaratne HR, Nanayakkara NP, Khan IA. 2002. Kavalactones from Piper methysticum, and their 13C NMR spectroscopic analyses. Phytochemistry. 59:429–433.
   PubMed Web of Science ®Google Scholar
• Folmer F, Blasius R, Morceau F, Tabudravu J, Dicato M, Jaspars M, Diederich M. 2006. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Biochem Pharmacol. 71:1206–1218.
   PubMed Web of Science ®Google Scholar
• Forman HJ, Dickinson DA. 2003. Oxidative signaling and glutathione synthesis. Biofactors. 17:1–12.
   PubMed Web of Science ®Google Scholar
• Geier FP, Konstantinowicz T. 2004. Kava treatment in patients with anxiety. Phytother Res. 18:297–300.
   PubMed Web of Science ®Google Scholar
• Gleitz J, Friese J, Beile A, Ameri A, Peters T. 1996. Anticonvulsive action of (+/-)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites. Eur J Pharmacol. 315:89–97.
   PubMed Web of Science ®Google Scholar
• Gounder R. 2006. Kava consumption and its health effects. Pac Health Dialog. 13:131–135.
   PubMedGoogle Scholar
• Hseu YC, Lee MS, Wu CR, Cho HJ, Lin KY, Lai GH, Wang SY, Kuo YH, Kumar KJ, Yang HL. 2012. The chalcone flavokawain B induces G2/M cell-cycle arrest and apoptosis in human oral carcinoma HSC-3 cells through the intracellular ROS generation and downregulation of the Akt/p38 MAPK signaling pathway. J Agric Food Chem. 60:2385–2397.
   PubMed Web of Science ®Google Scholar
• Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13:76–86.
   PubMed Web of Science ®Google Scholar
• Jacobs AT, Marnett LJ. 2010. Systems analysis of protein modification and cellular responses induced by electrophile stress. Acc Chem Res. 43:673–683.
   PubMed Web of Science ®Google Scholar
• Jhoo JW, Freeman JP, Heinze TM, Moody JD, Schnackenberg LK, Beger RD, Dragull K, Tang CS, Ang CY. 2006. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum). J Agric Food Chem. 54:3157–3162.
   PubMed Web of Science ®Google Scholar
• Kalmar B, Greensmith L. 2009. Induction of heat shock proteins for protection against oxidative stress. Adv Drug Deliv Rev. 61:310–318.
   PubMed Web of Science ®Google Scholar
• Kerns M, DePianto D, Yamamoto M, Coulombe PA. 2010. Differential modulation of keratin expression by sulforaphane occurs via Nrf2-dependent and -independent pathways in skin epithelia. Mol Biol Cell. 21:4068–4075.
   PubMed Web of Science ®Google Scholar
• Kim BR, Hu R, Keum YS, Hebbar V, Shen G, Nair SS, Kong AN. 2003. Effects of glutathione on antioxidant response element-mediated gene expression and apoptosis elicited by sulforaphane. Cancer Res. 63:7520–7525.
   PubMed Web of Science ®Google Scholar
• Kwon DJ, Ju SM, Youn GS, Choi SY, Park J. 2013. Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophages. Food Chem Toxicol. 58:479–486.
   PubMed Web of Science ®Google Scholar
• Lebot V, Lindstrom L, Merlin M. 1992. Kava: the pacific drug. New Haven (CT): Yale University Press.
   Google Scholar
• Lenzi M, Fimognari C, Hrelia P. 2014. Sulforaphane as a promising molecule for fighting cancer. Cancer Treat Res. 159:207–223.
   PubMedGoogle Scholar
• Li N, Liu JH, Zhang J, Yu BY. 2008. Comparative evaluation of cytotoxicity and antioxidative activity of 20 flavonoids. J Agric Food Chem. 56:3876–3883.
   PubMed Web of Science ®Google Scholar
• Li XZ, Ramzan I. 2010. Role of ethanol in kava hepatotoxicity. Phytother Res. 24:475–480.
   PubMed Web of Science ®Google Scholar
• Li Z, Srivastava P. 2004. Heat-shock proteins. Curr Protoc Immunol. Appendix 1:Appendix 1T.
   PubMedGoogle Scholar
• Liu Z, Xu X, Li X, Liu S, Simoneau AR, He F, Wu XR, Zi X. 2013. Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model. Cancer Prev Res (Phila). 6:1365–1375.
   PubMed Web of Science ®Google Scholar
• Lu SC. 2013. Glutathione synthesis. Biochim Biophys Acta. 1830:3143–3153.
   PubMed Web of Science ®Google Scholar
• Ma Q, He X. 2012. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev. 64:1055–1081.
   PubMed Web of Science ®Google Scholar
• Martin AC, Johnston E, Xing C, Hegeman AD. 2014. Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster). PLoS One. 9:e111572.
   Google Scholar
• McMahon M, Itoh K, Yamamoto M, Hayes JD. 2003. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem. 278:21592–21600.
   PubMed Web of Science ®Google Scholar
• Narayanapillai SC, Leitzman P, O'Sullivan MG, Xing C. 2014. Flavokawains A and B in kava, not dihydromethysticin, potentiate acetaminophen-induced hepatotoxicity in C57BL/6 mice. Chem Res Toxicol. 27:1871–1876.
   PubMed Web of Science ®Google Scholar
• Olsen LR, Grillo MP, Skonberg C. 2011. Constituents in kava extracts potentially involved in hepatotoxicity: a review. Chem Res Toxicol. 24:992–1002.
   PubMed Web of Science ®Google Scholar
• Qiu XB, Shao YM, Miao S, Wang L. 2006. The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cell Mol Life Sci. 63:2560–2570.
   PubMed Web of Science ®Google Scholar
• Samarasinghe B, Wales CT, Taylor FR, Jacobs AT. 2014. Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux. Biochem Pharmacol. 87:445–455.
   PubMed Web of Science ®Google Scholar
• Sarris J, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R, Savage KM, Dowell A, Ng C, Schweitzer I. 2013. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol. 33:643–648.
   PubMed Web of Science ®Google Scholar
• Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH. 2009. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci USA. 106:5171–5176.
   PubMed Web of Science ®Google Scholar
• Stocker R. 2004. Antioxidant activities of bile pigments. Antioxid Redox Signal. 6:841–849.
   PubMed Web of Science ®Google Scholar
• Tang Y, Li X, Liu Z, Simoneau AR, Xie J, Zi X. 2010. Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth. Int J Cancer. 127:1758–1768.
   PubMed Web of Science ®Google Scholar
• Tang Y, Simoneau AR, Xie J, Shahandeh B, Zi X. 2008. Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53. Cancer Prev Res (Phila). 1:439–451.
   PubMed Web of Science ®Google Scholar
• Teschke R. 2010a. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver Int. 30:1270–1279.
   PubMed Web of Science ®Google Scholar
• Teschke R. 2010b. Kava hepatotoxicity – a clinical review. Ann Hepatol. 9:251–265.
   PubMed Web of Science ®Google Scholar
• Teschke R, Genthner A, Wolff A. 2009. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures. J Ethnopharmacol. 123:378–384.
   PubMed Web of Science ®Google Scholar
• Teschke R, Qiu SX, Lebot V. 2011. Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits. Dig Liver Dis. 43:676–681.
   PubMedGoogle Scholar
• West JD, Marnett LJ. 2005. Alterations in gene expression induced by the lipid peroxidation product, 4-hydroxy-2-nonenal. Chem Res Toxicol. 18:1642–1653.
   PubMed Web of Science ®Google Scholar
• Zi X, Simoneau AR. 2005. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res. 65:3479–3486.
   PubMed Web of Science ®Google Scholar
• Zou J, Guo Y, Guettouche T, Smith DF, Voellmy R. 1998. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell. 94:471–480.
   PubMed Web of Science ®Google Scholar